Dr. Frank McCormick
Director of the University of California San Francisco (UCSF) Comprehensive Cancer Center and Cancer Research Institute, a multidisciplinary research and clinical care organization that is one of the largest matrix cancer centers in the Western United States. A native of Cambridge, England, McCormick received his B.Sc. in biochemistry from the University of Birmingham (1972) and his Ph.D. in biochemistry from the University of Cambridge (1975). Postdoctoral fellowships were held in the U.S. at the State University of New York at Stony Brook and in London at the Imperial Cancer Research Fund. He has been a Fellow of the Royal Society since 1996. Prior to joining the UCSF faculty, Dr. McCormick pursued cancer-related work with several Bay Area biotechnology firms, including positions with Cetus Corporation (Director of Molecular Biology, 1981-90; Vice President of Research, 1990-91) and Chiron Corporation, where he was Vice President of Research from 1991-92. In 1992 he founded Onyx Pharmaceuticals and served as its Chief Scientific Officer until 1996. In addition to his position as director of the UCSF Cancer Center, Frank McCormick holds the David A. Wood Chair of Tumor Biology and Cancer Research in UCSF's Department of Microbiology and Immunology. Dr. McCormick is the author of more than 200 scientific publications.
Brian Karlak
Brian Karlak has been developing high-end cheminformatics and bioinformatics applications for the past fifteen years at a variety of cutting-edge biotech companies, including Syrrx, Celera, and Perlegen Sciences. At Perlegen, Brian was responsible for the development and integration of their LIMS, data processing pipeline, and data visualization systems. At other companies, he has led development of an enterprise-wide tracking and monitoring system for high-throughput crystallography; an HMM-based system used to perform the first whole-genome functional analysis of the human genome; and a system for managing integrating the results from multiple bioinformatics analyses. Currently, Brian is helping build the world's most extensive open-data, open-source database at Metaweb Technologies.
|
